Mendus
Sweden - Stockholm
BiotechnologyFocus: Cell Therapy for Immuno-Oncology
Mendus is a life sciences company focused on Cell Therapy for Immuno-Oncology.
OncologyGene TherapyCell Therapy
Funding Stage
PUBLIC
Open Jobs
0
Pipeline & Clinical Trials
Phase 1
Clinical Trials (1)
NCT02686944A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Stromal Tumors
Phase 1ilixadencel
Carcinoma, Squamous Cell of Head and NeckClinical Trials (1)
NCT03735290A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer
Phase 1COMBIG-DC
Hepatocellular CarcinomaClinical Trials (1)
NCT01974661Phase I Safety Study of Dendritic Cell Vaccine to Treat Patients With Hepatocellular Carcinoma
Phase 1Combig-DC
Metastatic Renal Cell CarcinomaClinical Trials (1)
NCT01525017A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer
Phase 1DCP-001
Ovarian CancerClinical Trials (1)
NCT04739527Phase 1 Study to Evaluate the Safety, Feasibility and Immunogenicity of an Allogeneic, Cell-based Vaccine (DCP-001) in High Grade Serous Ovarian Cancer Patients After Primary Treatment
Phase 1DCP-001
Acute Myeloid Leukemia (AML)Clinical Trials (1)
NCT01373515Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia
Phase 1/2Phase 2
Clinical Trials (1)
NCT02432846Intratumoral Vaccination With Intuvax Pre-nephrectomy Followed by Sunitinib Post-nephrectomy vs Sunitinib Post-nephrectomy in Newly Diagnosed Metastatic Renal Cell Carcinoma (mRCC)
Phase 2Phase 2
Clinical Trials (1)
NCT03697707Efficacy and Safety of Immunotherapy With Allogeneic Dendritic Cells, DCP-001, in Patients With Acute Myeloid Leukaemia
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2022
Portfolio: 8 clinical trials